mRNA Therapies
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
213
NCT01935453
A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2012
Completion: Not specified
NCT03048253
A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c
Phase: N/A
Start: Mar 29, 2016
Completion: Oct 28, 2019
NCT04200040
A Clinical Study to Evaluate the Safety and Efficacy of OrienX010 in Unresectable Malignant Melanoma Patients
Phase: Phase 2
Start: Aug 27, 2017
Completion: Dec 27, 2022
Loading map...